Viral Factors Important for Efficient Replication of Influenza A Viruses in Cells of the Central Nervous System.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 18 12 2018
accepted: 05 03 2019
pubmed: 15 3 2019
medline: 24 6 2020
entrez: 15 3 2019
Statut: epublish

Résumé

Central nervous system (CNS) disease is one of the most common extrarespiratory tract complications of influenza A virus infections. Remarkably, zoonotic H5N1 virus infections are more frequently associated with CNS disease than seasonal or pandemic influenza viruses. Little is known about the interaction between influenza A viruses and cells of the CNS; therefore, it is currently unknown which viral factors are important for efficient replication. Here, we determined the replication kinetics of a seasonal, pandemic, zoonotic, and lab-adapted influenza A virus in human neuron-like (SK-N-SH) and astrocyte-like (U87-MG) cells and primary mouse cortex neurons. In general, highly pathogenic avian influenza (HPAI) H5N1 virus replicated most efficiently in all cells, which was associated with efficient attachment and infection. Seasonal H3N2 and to a lesser extent pandemic H1N1 virus replicated in a trypsin-dependent manner in SK-N-SH but not in U87-MG cells. In the absence of trypsin, only HPAI H5N1 and WSN viruses replicated. Removal of the multibasic cleavage site (MBCS) from HPAI H5N1 virus attenuated, but did not abrogate, replication. Taken together, our results showed that the MBCS and, to a lesser extent, the ability to attach are important determinants for efficient replication of HPAI H5N1 virus in cells of the CNS. This suggests that both an alternative hemagglutinin (HA) cleavage mechanism and preference for α-2,3-linked sialic acids allowing efficient attachment contribute to the ability of influenza A viruses to replicate efficiently in cells of the CNS. This study further improves our knowledge on potential viral factors important for the neurotropic potential of influenza A viruses.

Identifiants

pubmed: 30867311
pii: JVI.02273-18
doi: 10.1128/JVI.02273-18
pmc: PMC6532103
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Siegers et al.

Références

Arch Virol. 2000;145(1):187-95
pubmed: 10664417
J Virol. 2001 Jul;75(14):6687-91
pubmed: 11413336
J Virol. 2001 Oct;75(19):9297-301
pubmed: 11533192
Science. 2001 Sep 7;293(5536):1840-2
pubmed: 11546875
J Virol. 2002 May;76(9):4420-9
pubmed: 11932409
Arch Virol. 2002 Jul;147(7):1425-36
pubmed: 12111416
Med Klin. 1975 Nov 21;70(47):1910-4
pubmed: 1214696
J Virol. 2003 Mar;77(6):3816-23
pubmed: 12610156
Vet Microbiol. 2003 Aug 29;95(1-2):1-13
pubmed: 12860072
Lancet. 1958 Jul 5;2(7036):11-5
pubmed: 13564746
Lancet. 1958 Jul 5;2(7036):15-7
pubmed: 13564747
Viral Immunol. 2003;16(3):415-23
pubmed: 14583155
Am J Pathol. 2004 Feb;164(2):419-28
pubmed: 14742248
Vet Pathol. 2004 Mar;41(2):101-7
pubmed: 15017022
Virology. 2004 Aug 1;325(2):340-50
pubmed: 15246273
Acta Neuropathol. 2004 Dec;108(6):485-92
pubmed: 15480712
Emerg Infect Dis. 2004 Dec;10(12):2189-91
pubmed: 15663858
N Engl J Med. 2005 Feb 17;352(7):686-91
pubmed: 15716562
Eur J Endocrinol. 2005 Jan;152(1):143-53
pubmed: 15762198
Emerg Infect Dis. 2005 May;11(5):699-701
pubmed: 15890122
Science. 2005 Oct 7;310(5745):77-80
pubmed: 16210530
EMBO J. 1992 Jul;11(7):2407-14
pubmed: 1628614
J Mol Biol. 2006 Feb 3;355(5):1143-55
pubmed: 16343533
Am J Pathol. 2006 Jan;168(1):176-83; quiz 364
pubmed: 16400021
J Gen Virol. 2007 Apr;88(Pt 4):1281-7
pubmed: 17374773
J Comp Pathol. 2007 Aug-Oct;137(2-3):155-9
pubmed: 17689552
Am J Pathol. 2007 Oct;171(4):1215-23
pubmed: 17717141
Lancet. 2007 Sep 29;370(9593):1137-45
pubmed: 17905166
Travel Med Infect Dis. 2008 May;6(3):114-24
pubmed: 18486065
Hum Pathol. 2009 May;40(5):735-9
pubmed: 19121843
J Virol. 2009 Apr;83(7):3200-11
pubmed: 19158246
Vaccine. 2008 Sep 12;26 Suppl 4:D59-66
pubmed: 19230162
Med Hypotheses. 2010 May;74(5):798-801
pubmed: 20060230
Neuroscience. 2010 Jul 14;168(3):613-23
pubmed: 20398740
J Virol. 2010 Aug;84(16):7953-60
pubmed: 20519405
Rev Med Virol. 2010 Sep;20(5):298-310
pubmed: 20629046
Virology. 2010 Dec 5;408(1):128-133
pubmed: 20926110
J Virol. 2011 Feb;85(4):1554-62
pubmed: 21123387
J Gen Virol. 2011 Jun;92(Pt 6):1410-5
pubmed: 21346026
J Virol. 2011 May;85(10):5202-7
pubmed: 21389133
Am J Pathol. 2011 Jul;179(1):30-6
pubmed: 21640972
J Leukoc Biol. 2012 Jul;92(1):97-106
pubmed: 22124137
J Virol. 2012 Apr;86(7):3975-84
pubmed: 22278228
Curr Opin Virol. 2012 Apr;2(2):160-7
pubmed: 22445963
Acta Neuropathol. 2012 Oct;124(4):505-16
pubmed: 22763823
Scand J Infect Dis. 2012 Dec;44(12):992-6
pubmed: 22803773
BMC Microbiol. 2012 Aug 01;12:162
pubmed: 22853823
PLoS One. 2012;7(8):e42343
pubmed: 22905124
Neurology. 2012 Oct 2;79(14):1474-81
pubmed: 22993280
N Engl J Med. 2013 May 16;368(20):1888-97
pubmed: 23577628
J Chem Neuroanat. 2013 Sep;52:49-57
pubmed: 23726946
Emerg Infect Dis. 2013 Jun;19(6):1005-7
pubmed: 23735733
Pathog Dis. 2013 Nov;69(2):87-100
pubmed: 23821437
Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):479-90
pubmed: 24078062
J Infect Dis. 2014 Aug 1;210(3):419-23
pubmed: 24550441
Viruses. 2015 May 22;7(5):2618-40
pubmed: 26008703
Eur J Cell Biol. 2015 Jul-Sep;94(7-9):375-83
pubmed: 26095298
PLoS One. 2015 Aug 14;10(8):e0135850
pubmed: 26274828
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E368-77
pubmed: 26668381
Emerg Infect Dis. 2017 Apr;23(4):574-581
pubmed: 28322689
Lancet. 2017 Jun 3;389(10085):2172-2174
pubmed: 28589883
Influenza Other Respir Viruses. 2017 Sep;11(5):372-393
pubmed: 28745014
J Infect Dis. 2017 Oct 17;216(7):829-833
pubmed: 28973159
Clin Infect Dis. 2018 Jan 6;66(1):136-139
pubmed: 29020163
J Biol Chem. 2017 Dec 15;292(50):20669-20682
pubmed: 29054928
J Infect Dis. 2018 Mar 28;217(8):1237-1246
pubmed: 29329410
J Neurosci. 2018 Mar 21;38(12):3060-3080
pubmed: 29487124
J Neurovirol. 2018 Dec;24(6):752-760
pubmed: 29987581
J Neurovirol. 2019 Apr;25(2):275-279
pubmed: 30397824
Br Med J. 1971 Feb 13;1(5745):369-73
pubmed: 4322460
J Exp Med. 1995 Jun 1;181(6):2161-9
pubmed: 7760004
J Virol. 1993 Nov;67(11):6667-73
pubmed: 8411368
Lancet. 1998 Sep 12;352(9131):873-5
pubmed: 9742980
J Virol Methods. 1998 Sep;74(1):57-66
pubmed: 9763129

Auteurs

Jurre Y Siegers (JY)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Marco W G van de Bildt (MWG)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Zhanmin Lin (Z)

Department of Neuroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Lonneke M Leijten (LM)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Rémon A M Lavrijssen (RAM)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Theo Bestebroer (T)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Monique I J Spronken (MIJ)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Chris I De Zeeuw (CI)

Department of Neuroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Zhenyu Gao (Z)

Department of Neuroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Eefje J A Schrauwen (EJA)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Thijs Kuiken (T)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Debby van Riel (D)

Department of Viroscience, Erasmus MC Rotterdam, Rotterdam, the Netherlands d.vanriel@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH